Protein A Resins Market Size, Share, and Trends 2024 to 2034

The global market size is calculated at USD 1.67 billion in 2025 and is forecasted to reach around USD 2.73 billion by 2034, accelerating at a CAGR of 5.62% from 2025 to 2034. The North America market size surpassed USD 660 million in 2024 and is expanding at a CAGR of 5.80% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 4063
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein A Resins Market 

5.1. COVID-19 Landscape: Protein A Resins Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein A Resins Market, By Application

8.1. Protein A Resins Market Revenue and Volume Forecast, by Application

8.1.1. Antibody purification

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Immunoprecipitation

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Protein A Resins Market, By Product

9.1. Protein A Resins Market Revenue and Volume Forecast, by Product

9.1.1. Recombinant protein A

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Natural protein A

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Protein A Resins Market, By Matrix Type 

10.1. Protein A Resins Market Revenue and Volume Forecast, by Matrix Type

10.1.1. Agarose-based matrix

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Glass or silica gel-based matrix

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Organic polymer-based matrix

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Protein A Resins Market, By End-user 

11.1. Protein A Resins Market Revenue and Volume Forecast, by End-user

11.1.1. Pharmaceutical & Biopharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Clinical research laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Academic research institutes

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Contract research organization

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Protein A Resins Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Application

12.1.2. Market Revenue and Volume Forecast, by Product

12.1.3. Market Revenue and Volume Forecast, by Matrix Type

12.1.4. Market Revenue and Volume Forecast, by End-user

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Application

12.1.5.2. Market Revenue and Volume Forecast, by Product

12.1.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.1.5.4. Market Revenue and Volume Forecast, by End-user

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Application

12.1.6.2. Market Revenue and Volume Forecast, by Product

12.1.6.3. Market Revenue and Volume Forecast, by Matrix Type

12.1.6.4. Market Revenue and Volume Forecast, by End-user

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Application

12.2.2. Market Revenue and Volume Forecast, by Product

12.2.3. Market Revenue and Volume Forecast, by Matrix Type

12.2.4. Market Revenue and Volume Forecast, by End-user

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Application

12.2.5.2. Market Revenue and Volume Forecast, by Product

12.2.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.2.5.4. Market Revenue and Volume Forecast, by End-user

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Application

12.2.6.2. Market Revenue and Volume Forecast, by Product

12.2.6.3. Market Revenue and Volume Forecast, by Matrix Type

12.2.6.4. Market Revenue and Volume Forecast, by End-user

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Application

12.2.7.2. Market Revenue and Volume Forecast, by Product

12.2.7.3. Market Revenue and Volume Forecast, by Matrix Type

12.2.7.4. Market Revenue and Volume Forecast, by End-user

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Application

12.2.8.2. Market Revenue and Volume Forecast, by Product

12.2.8.3. Market Revenue and Volume Forecast, by Matrix Type

12.2.8.4. Market Revenue and Volume Forecast, by End-user

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Application

12.3.2. Market Revenue and Volume Forecast, by Product

12.3.3. Market Revenue and Volume Forecast, by Matrix Type

12.3.4. Market Revenue and Volume Forecast, by End-user

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Application

12.3.5.2. Market Revenue and Volume Forecast, by Product

12.3.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.3.5.4. Market Revenue and Volume Forecast, by End-user

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Application

12.3.6.2. Market Revenue and Volume Forecast, by Product

12.3.6.3. Market Revenue and Volume Forecast, by Matrix Type

12.3.6.4. Market Revenue and Volume Forecast, by End-user

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Application

12.3.7.2. Market Revenue and Volume Forecast, by Product

12.3.7.3. Market Revenue and Volume Forecast, by Matrix Type

12.3.7.4. Market Revenue and Volume Forecast, by End-user

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Application

12.3.8.2. Market Revenue and Volume Forecast, by Product

12.3.8.3. Market Revenue and Volume Forecast, by Matrix Type

12.3.8.4. Market Revenue and Volume Forecast, by End-user

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Application

12.4.2. Market Revenue and Volume Forecast, by Product

12.4.3. Market Revenue and Volume Forecast, by Matrix Type

12.4.4. Market Revenue and Volume Forecast, by End-user

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Application

12.4.5.2. Market Revenue and Volume Forecast, by Product

12.4.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.4.5.4. Market Revenue and Volume Forecast, by End-user

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Application

12.4.6.2. Market Revenue and Volume Forecast, by Product

12.4.6.3. Market Revenue and Volume Forecast, by Matrix Type

12.4.6.4. Market Revenue and Volume Forecast, by End-user

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Application

12.4.7.2. Market Revenue and Volume Forecast, by Product

12.4.7.3. Market Revenue and Volume Forecast, by Matrix Type

12.4.7.4. Market Revenue and Volume Forecast, by End-user

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Application

12.4.8.2. Market Revenue and Volume Forecast, by Product

12.4.8.3. Market Revenue and Volume Forecast, by Matrix Type

12.4.8.4. Market Revenue and Volume Forecast, by End-user

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Application

12.5.2. Market Revenue and Volume Forecast, by Product

12.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.5.4. Market Revenue and Volume Forecast, by End-user

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Application

12.5.5.2. Market Revenue and Volume Forecast, by Product

12.5.5.3. Market Revenue and Volume Forecast, by Matrix Type

12.5.5.4. Market Revenue and Volume Forecast, by End-user

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Application

12.5.6.2. Market Revenue and Volume Forecast, by Product

12.5.6.3. Market Revenue and Volume Forecast, by Matrix Type

12.5.6.4. Market Revenue and Volume Forecast, by End-user

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Merck Millipore

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PerkinElmer, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. GenScript Biotech Corp.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Agilent Technologies

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Repligen Corp.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Thermo Fisher Scientific Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bio-Rad Laboratories, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Abcam PLC.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Novasep Holdings SAS

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global protein A resins market size is expected to increase USD 2.74 billion by 2033 from USD 1.58 billion in 224.

The global protein A resins market will register growth rate of 5.62% between 2025 and 2034.

The major players operating in the protein a resins market are GE Healthcare, Merck Millipore, PerkinElmer, Inc., GenScript Biotech Corp., Agilent Technologies, Repligen Corp., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam PLC., Novasep Holdings SAS and Others.

The driving factors of the protein a resins market are the rising investments in synthetic biology and the expansion of the overall global pharmaceutical industry.

North America region will lead the global protein a resins market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client